CPhI 2022, November 1-3
Are we going to be present at the next CPhI in Frankfurt? We are, of course! For three days, from November 1st to 3rd, we have the opportunity to reaf...
Read MoreCF@BO 2021, September 10 – 11
ABOUT THE CH@BO n.11 ONLINE CONVENTION Because of the uncertainties still associated with the pandemic of SARS-COVID-19 the 11th edition of the Bologn...
Read More
Des-Methyl-Venlafaxine Salt
New Crystalline Forms of Des-Methyl-Venlafaxine Salt Discovered PolyCrystalLine s.r.l. and Segrub Pharmaceuticals have developed a gene...
Read MoreIMAZAMOX: A Quest for Polymorphic Modifications of a Chiral and Racemic Herbicid
ABSTRACT: The structure−property relationships of new polymorphs of the chiral herbicide imazamox were investigated by X-ray diffraction, hot s...
Read More
Join us at CPhI Worldwide – Milan 2021
We invite you to join us at our booth n. 4H93 and learn more about our capabilities: Solid Form Development Crystallization Optimization Analytical Se...
Read MoreMeet us at DCAT in New York!
We invite you to join us in our meeting room at the Intercontinental Suite #510/511 and learn more about our capabilities: Solid Form Development Crys...
Read More
Controlled Substances Studies & Analysis
PolyCrystalLine received the authorization N°101/2017 from the Italian Ministry of Healthfor the study and chemical/physical analysis of controlled s...
Read More
MyCrystalPro: Our Online Portal
Polycrystalline can be entrusted with your most sensitive projects for method development and validation of API’s intermediates, raw materials and f...
Read MorePolyCrystalLine CDMO is on the way
PolyCrystalLine CDMO is on the way.Keep following us for the updates on the progress of our brand new facilities! Next generation of CR-DMO specialize...
Read More
Polymorphs of Dex-Lansoprazole
New Crystalline Forms of Dex-Lansoprazole Discovered PolyCrystalLine s.r.l. and Segrub Pharmaceuticals have developed a generic equivalent to Kap...
Read More
Highly Potent API
Polycrystalline is expanding its HPAPI offerings, up to OEB 5 level of containment for the synthesis, study and development of anti-cancer and cytotox...
Read MoreFRENCH CERTIFICATION
PolyCrystalLine s.r.l. received the approval from French Health Ministry as a CRO for R&D activities, the French companies who use our services ca...
Read More
GMP CERTIFICATION
PolyCrystalLine received the audit from the Health Agency for the cGMP certification. PolyCrystalLine received the audit from the Health Agency for th...
Read MoreMonodronic Acid Novel Form
PolyCrystalLine discovered a novel crystalline form of Minodronic Acid and filed a patent application. For additional information contact info@po...
Read More
Sostanze Altamente Attive: Rischi e Contenimento
Polycrystalline, CSV Life Science e Pharma-Hub organizzano la Giornata di Studio sul tema “SOSTANZE ALTAMENTE ATTIVE: RISCHI E CONTENIMENTO...
Read More